Stocks · Health care · Pharmaceutical Preparations

Rapport Therapeutics, Inc.

RAPP Clue Score46
United States Fiscal year ends December CIK 0002012593 Results filed 4 Nov 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Cheryl Gault
5 Mar 2026
Chief Operating Officer
Sell
2,014
$28.93
$58.27K
Krishnaswamy Yeleswaram
31 Dec 2025
Chief Development Officer
Sell
2,840
$30.05
$85.34K
David Bredt
31 Dec 2025
Chief Scientific Officer
Sell
6,567
$30.05
$197.34K

What was left out

Form 4 filings counted 101
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 7
Sales on a Rule 10b5-1 plan 87
Sales straight out of an exercise 2
Sales at will 3
Transactions with no price 0
Shares from compensation/vesting 14,127,701
History held since 10 Jun 2024